Want to see AU:CBL full AI Analyst Report?
Total Valuation
Control Bionics Ltd. has a market cap or net worth of AU$32.70M. The enterprise value is AU$25.95M.
Market CapAU$32.70M
Enterprise ValueAU$25.95M
Share Statistics
Control Bionics Ltd. has 441,897,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding441,897,670
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Control Bionics Ltd.’s return on equity (ROE) is -1.11 and return on invested capital (ROIC) is -90.66%.
Return on Equity (ROE)-1.11
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)-90.66%
Return on Capital Employed (ROCE)-1.03
Revenue Per Employee245.80K
Profits Per Employee-244.35K
Employee Count25
Asset Turnover0.75
Inventory Turnover4.96
Valuation Ratios
The current PE Ratio of Control Bionics Ltd. is ―. Control Bionics Ltd.’s PEG ratio is 0.03.
PE Ratio―
PS Ratio1.29
PB Ratio1.44
Price to Fair Value1.44
Price to FCF-1.73
Price to Operating Cash Flow-6.02
PEG Ratio0.03
Income Statement
In the last 12 months, Control Bionics Ltd. had revenue of 6.14M and earned -6.11M in profits. Earnings per share was -0.02.
Revenue6.14M
Gross Profit4.11M
Operating Income-5.83M
Pretax Income-6.11M
Net Income-6.11M
EBITDA-5.14M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -4.13M and capital expenditures -337.99K, giving a free cash flow of -4.46M billion.
Operating Cash Flow-4.13M
Free Cash Flow-4.46M
Free Cash Flow per Share-0.01
Dividends & Yields
Control Bionics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.15
52-Week Price Change134.37%
50-Day Moving Average0.07
200-Day Moving Average0.06
Relative Strength Index (RSI)55.90
Average Volume (3m)173.99K
Important Dates
Control Bionics Ltd. upcoming earnings date is Aug 27, 2026, After Close (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Control Bionics Ltd. as a current ratio of 1.24, with Debt / Equity ratio of 3.34%
Current Ratio1.24
Quick Ratio1.08
Debt to Market Cap0.01
Net Debt to EBITDA0.03
Interest Coverage Ratio-53.50
Taxes
In the past 12 months, Control Bionics Ltd. has paid -426.63K in taxes.
Income Tax-426.63K
Effective Tax Rate0.07
Enterprise Valuation
Control Bionics Ltd. EV to EBITDA ratio is -1.51, with an EV/FCF ratio of -1.70.
EV to Sales1.26
EV to EBITDA-1.51
EV to Free Cash Flow-1.70
EV to Operating Cash Flow-1.82
Balance Sheet
Control Bionics Ltd. has AU$3.06M in cash and marketable securities with AU$258.10K in debt, giving a net cash position of AU$2.80M billion.
Cash & Marketable SecuritiesAU$3.06M
Total DebtAU$258.10K
Net CashAU$2.80M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 5.38%, with operating margin of -94.87%, and net profit margin of -99.41%.
Gross Margin5.38%
Operating Margin-94.87%
Pretax Margin-99.41%
Net Profit Margin-99.41%
EBITDA Margin-83.64%
EBIT Margin-96.95%
Analyst Forecast
The average price target for Control Bionics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast14.88%
EPS Growth Forecast35.94%